BPIQ Blog

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jul 25, 20221 min read

Biopharma Mid Morning Pulse - 07/25/22

(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 25, 20221 min read

Free Biopharma Mid Morning Pulse - 07/25/22

(Posted 10:15am CST) $XBI $80 | -0.84% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...

Jul 5, 20222 min read

Biopharma Pulse - June Month in Review

As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...

Jun 24, 20223 min read

Biopharma Pulse - 6/20-6/24 Week in Review

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

Jun 22, 20222 min read

Biopharma Daily Stock Updates - 06/22/22

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

Jun 22, 20222 min read

Free Biopharma Daily Stock Updates - 06/22/22

$XBI $71.79 | +2.51% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #MDNA +14.4% Moderna Announces...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity